Client and counselor attitudes toward the use of medications for treatment of opioid dependence

scientific article

Client and counselor attitudes toward the use of medications for treatment of opioid dependence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JSAT.2006.09.002
P932PMC publication ID2847884
P698PubMed publication ID17306729
P5875ResearchGate publication ID6498309

P50authorTraci RieckmannQ47378631
P2093author name stringDennis McCarty
Cindy P Thomas
Bret E Fuller
Marilyn Daley
P2860cites workA multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkQ24548339
Medications for alcohol, illicit drug, and tobacco dependence. An update of research findingsQ33534318
The theory of planned behavior: a review of its applications to health-related behaviorsQ33573653
Pharmacological treatment of alcohol dependence: a review of the evidenceQ33596810
Drug therapy for alcohol dependenceQ33631182
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experienceQ34081656
Effects of managed care on programs and practices for the treatment of alcohol and drug dependence.Q34306362
Behavioral science and public health: a necessary partnership for HIV preventionQ34405929
Buprenorphine for acute heroin detoxification: diffusion of research into practiceQ36738505
A range of research-based pharmacotherapies for addictionQ41602489
Research to practice: adoption of naltrexone in alcoholism treatmentQ44368411
Staff beliefs about addiction treatmentQ47612604
Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics.Q51105478
Physicians' attitudes and retention of patients in their methadone maintenance programs.Q51114221
Attitudes and beliefs of staff working in methadone maintenance clinics.Q51115787
Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism.Q52276448
Attitudes, beliefs and alcohol use. An analysis of relationships.Q52282374
Normative and attitudinal control as moderating influences on marijuana useQ67368977
Dispelling the myths about addiction: strategies to increase understanding and strengthen researchQ95433356
P433issue2
P921main subjectopioidQ427523
P304page(s)207-215
P577publication date2006-12-08
P1433published inJournal of Substance Abuse TreatmentQ15762042
P1476titleClient and counselor attitudes toward the use of medications for treatment of opioid dependence
P478volume32

Reverse relations

cites work (P2860)
Q58165046A Perspective from the Field: The Disconnect between Abstinence-Based Programs and the Use of Motivational Interviewing in Treating Substance Use Disorders
Q34503746A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients
Q36364490A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment
Q37498637A qualitative study of the adoption of buprenorphine for opioid addiction treatment
Q34607338Adoption and implementation of medications in addiction treatment programs
Q36806539Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities
Q33621921Attitudes toward buprenorphine and methadone among opioid-dependent individuals
Q33576948Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program
Q36522103Clinician attitudes, social norms and intentions to use a computer-assisted intervention
Q37241381Clinician beliefs and attitudes about buprenorphine/naloxone diversion
Q37199683Community-based addiction treatment staff attitudes about the usefulness of evidence-based addiction treatment and CBO organizational linkages to research institutions
Q37087764Counselor attitudes toward and use of evidence-based practices in private substance use disorder treatment centers: a comparison of social workers and non-social workers
Q36934945Counselor training and attitudes toward pharmacotherapies for opioid use disorder.
Q34076189Diffusion of Contingency Management and Attitudes regarding Its Effectiveness and Acceptability
Q34111054Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations
Q35602408How do providers serving American Indians and Alaska Natives with substance abuse problems define evidence-based treatment?
Q33776944Impact of research network participation on the adoption of buprenorphine for substance abuse treatment
Q35400440Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.
Q37033705Improving acceptance of naltrexone in community addiction treatment centers: a pilot study
Q39181057Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment.
Q34389080Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice
Q44350841Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment
Q52300834Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew.
Q42289728NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale
Q36967059Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification
Q39834450Perceptions Related to Pharmacological Treatment of Opioid Dependence Among Individuals Seeking Treatment at a Tertiary Care Center in Northern India: A Descriptive Study
Q89792570Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders
Q39739647Probation Staff Attitudes Toward Substance Abuse Treatment and Evidence-Based Practices
Q33803543Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment Organizations
Q37224883Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review
Q33625968Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment
Q44135207Substance use treatment counselors' attitudes toward evidence-based practice: the importance of organizational context
Q89854785Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic
Q35032811The impact of pay-for-performance on therapists' intentions to deliver high-quality treatment
Q36364478The substance abuse counseling workforce: education, preparation, and certification
Q35577449Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages
Q35875486Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis
Q37115985Two Models of Integrating Buprenorphine Treatment and Medical Staff within Formerly "Drug-Free" Outpatient Programs

Search more.